Report Overview
About Cord Blood Banking Services
Cord blood is the blood in the umbilical cord of a newborn. It contains stem cells that can grow into blood vessels, tissues, and organs. Cord blood stem cells are subjected to Food and Drug Administration (FDA)-regulated clinical trials to find out their suitability in treating diseases such as autism, brain injury, and other conditions. Cord blood banking is the process of collecting cord blood and cryogenically freezing it for medical use in future.
Technavio’s analysts forecast the global cord blood banking services market to grow at a CAGR of 5.59% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global cord blood banking services market for 2017-2021. To calculate the market size, the report considers revenue generated from the services provided by public as well as private cord blood banks.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Cord Blood Banking Services Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• CBR
• Cryo-Cell
• StemCyte
• ViaCord
Other prominent vendors
• Americord
• China Cord Blood Corporation
• Cryo-Save
• Cryoviva India
• CordVida
• LifeCell International
• Vita34
Market driver
• Rise in federal funding for stem cell therapy
• For a full, detailed list, view our report
Market challenge
• Ethical concerns with respect to stem cell research
• For a full, detailed list, view our report
Market trend
• Increase in inorganic growth strategies
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table Of Contents
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market landscape
• Market size and forecast
• Strategic alliances
• Five forces analysis
PART 05: Geographic segmentation
• Global cord blood banking services market by geography
• Cord blood banking services market in Americas
• Cord blood banking services market in EMEA
• Cord blood banking services market in APAC
PART 06: By storage
• Global cord blood banking services market by storage
• Private cord blood banking services market
• Public cord blood banking services market
PART 07: Decision framework
PART 08: Drivers and challenges
• Market drivers
• Market challenges
PART 09: Market trends
• Increase in inorganic growth strategies
• Greater demand for personalized medicines
• Growing acceptance of stem cell therapies
• Increase in automation of cord blood processing
PART 10: Vendor landscape
• Competitive landscape
PART 11: Key vendor analysis
• CBR
• Cryo-Cell
• StemCyte
• ViaCord
• Other prominent vendors
PART 12: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Comparison of stem cell sources
Exhibit 02: Cord blood banking timeline
Exhibit 03: Global cord blood banking services market 2016-2021 ($ millions)
Exhibit 04: Five forces analysis
Exhibit 05: Global cord blood banking services market by geography 2016-2021 (% share)
Exhibit 06: Cord blood banking services market in Americas 2016-2021 ($ millions)
Exhibit 07: Cord blood banking services market in EMEA 2016-2021 ($ millions)
Exhibit 08: Cord blood banking services market in APAC 2016-2021 ($ millions)
Exhibit 09: Global cord blood banking services market by storage 2016-2021 (% share)
Exhibit 10: Private cord blood banking services market 2016-2021 ($ millions)
Exhibit 11: Public cord blood banking services market 2016-2021 ($ millions)
Exhibit 12: Expected cancer cases and deaths by 2030
Exhibit 13: NIH: YoY and growth rate of spending toward stem cell research 2013-2016 ($ billions)
Exhibit 14: Breakdown of CIRM funding in stem cell research in 2014 ($ billions)
Exhibit 15: Active programs under CIRM in 2014
Exhibit 16: Details of European Commission funding
Exhibit 17: Programs in US providing free cord blood banking services
Exhibit 18: CBR: Strength analysis
Exhibit 19: CBR: Strategy assessment
Exhibit 20: CBR: Opportunity assessment
Exhibit 21: Cryo-Cell: Strength analysis
Exhibit 22: Cryo-Cell: Strategy assessment
Exhibit 23: Cryo-Cell: Opportunity assessment
Exhibit 24: StemCyte: Strength analysis
Exhibit 25: StemCyte: Strategy assessment
Exhibit 26: StemCyte: Opportunity assessment
Exhibit 27: ViaCord: Strength analysis
Exhibit 28: ViaCord: Strategy assessment
Exhibit 29: ViaCord: Opportunity assessment